PHARMA MAR, S.A. from 01/03/2021 to 01/03/2021 01/03/2021 09:22 PHARMA MAR, S.A. On business and financial situation The Company announces the signature of a new license agreement with Adium to commercialize Zepzelca® (lurbinectedin) in Latin America. Register number: 7654